This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
6 - 8 June, 2023
Postillon Hotel AmsterdamDigital Experience: All Sessions Live-streamed 6-8 June, 2023

Achim Doerner
Principal Scientist, Protein Engineering and Antibody Technologies at Merck Healthcare KGaA


A biochemist by training, Achim has been working with bispecific antibodies or ADCs and technology development for their effective screening. In one flavour, screening of such and further complex NBEs is realized applying versatile microfluidics and in part in conjunction with mammalian libraries enabling rapid antibody hit discovery and optimization.

Agenda Sessions

  • Mammalian Antibody Display and Secretion for Microfluidic Hit Discovery